Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis

Heart Failure

Lateral QRS amplitude is independently associated with outcome after cardiac resynchronization therapy: advancing patient selection?

Heart Rhythm

Trenson S, Kahr PC, Schwaiger JM, Betschart P, Kuster J, Vandenberk B, Duchenne J, Beela AS, Stankovic I, Voros G, Flammer AJ, Schindler M, Saguner AM, Willems R, Ruschitzka F, Steffel J, Breitenstein A, Voigt JU, Winnik S

doi: 10.1016/j.hrthm.2024.10.031

Heart Failure

New York Heart Association functional class and implantable cardioverter-defibrillator in non-ischaemic heart failure with reduced ejection fraction: Extended follow-up of the DANISH trial

Eur J Heart Fail

Karacan MN, Doi SN, Yafasova A, Thune JJ, Nielsen JC, Haarbo J, Bruun NE, Gustafsson F, Eiskjær H, Hassager C, Svendsen JH, Høfsten DE, Pehrson S, Køber L, Butt JH

doi: 10.1002/ejhf.3239

Heart Failure

Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

ESC Heart Fail

García-Bolao I, Gardner RS, Gras D, D'Onofrio A, Mark G, Nair D, Lellouche N, Novak M, Lo R, Chew E, Wright D, Kaplan A, Bertini M, Veraghtert S, Harbin MM, Matznick E, Yong P, Stein KM

doi: 10.1002/ehf2.15190

Heart Failure

Finerenone and New York Heart Association Functional Class in Heart Failure: The FINEARTS-HF Trial

JACC Heart Fail

Ostrominski JW, Vaduganathan M, Claggett BL, Desai AS, Jhund PS, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Borentian M, Rohwedder K, Lay-Flurrie J, Lavagnino MA, McMurray JJV, Solomon SD

doi: 10.1016/j.jchf.2025.03.007

Heart, Artery and Coronary Diseases

De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials

Lancet

Valgimigli M, Hong SJ, Gragnano F, Chalkou K, Franzone A, da Costa BR, Baber U, Kim BK, Jang Y, Chen SL, Stone GW, Hahn JY, Windecker S, Gibson MC, Song YB, Ge Z, Vranckx P, Mehta S, Gwon HC, Lopes RD, Dangas GD, McFadden EP, Angiolillo DJ, Leonardi S, Heg D, Calabrò P, Jüni P, Mehran R, Hong MK, Single Versus Dual Antiplatelet Therapy (Sidney-4) collaborator group

doi: 10.1016/S0140-6736(24)01616-7

Heart Failure

Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis

Eur J Heart Fail

Karakasis P, Lefkou E, Pamporis K, Farmakis D, Patoulias D, Antoniadis AP, Heymans S, Filippatos G, Fragakis N

doi: 10.1002/ejhf.3637

Atrial FibrillationHeart Failure

Catheter Ablation Versus Medical Therapy for Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-analysis

Heart Rhythm

Bulhões E, Antunes VLJ, Mazetto R, Defante MLR, Garcia AC, Guida C

doi: 10.1016/j.hrthm.2024.04.058

Heart Failure

Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry

Eur J Heart Fail

Shahim A, Linde C, Savarese G, Dahlström U, Lund LH, Hage C

doi: 10.1002/ejhf.3565

Heart, Artery and Coronary DiseasesMyocardial Infarction

Ineffective Cardiac Resynchronization Pacing is Associated with Poor Outcomes in a Nationwide Cohort Analysis

Heart Rhythm

Robbins-Juarez SY, Mittal S, Plummer C, Koehler JL, Stadler RW, Ghosh S, Klepfer RN, Piccini JP

doi: 10.1016/j.hrthm.2024.06.064

Related content

Lateral QRS amplitude is independently associated with outcome after cardiac resynchronization therapy: advancing patient selection?

New York Heart Association functional class and implantable cardioverter-defibrillator in non-ischaemic heart failure with reduced ejection fraction: Extended follow-up of the DANISH trial

Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

Finerenone and New York Heart Association Functional Class in Heart Failure: The FINEARTS-HF Trial

De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials

Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis

Catheter Ablation Versus Medical Therapy for Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-analysis

Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry

Ineffective Cardiac Resynchronization Pacing is Associated with Poor Outcomes in a Nationwide Cohort Analysis